Featured Research

from universities, journals, and other organizations

Enzyme Inhibitor Takes An Unexpected Approach Toward Blocking Cancer-promoting Protein

Date:
September 9, 2009
Source:
Fox Chase Cancer Center
Summary:
Scientists have discovered a unique method of attack that may be used to inhibit signaling enzymes called kinases, which often have a role in sustaining drug-resistant cancerous cells. They have confirmed that IPA-3, a small molecular inhibitor of a kinase called PAK1, targets the enzyme's regulatory domain, mimicking how enzymes are naturally regulated within cells.

Scientists at Fox Chase Cancer Center have discovered a unique method of attack that may be used to inhibit signaling enzymes called kinases, which often have a role in sustaining drug-resistant cancerous cells. They have confirmed that IPA-3, a small molecular inhibitor of a kinase called PAK1, targets the enzyme's regulatory domain, mimicking how enzymes are naturally regulated within cells.

"Typically, research has focused on ways of blocking the active site of enzymes, the part of the enzyme that performs a particular task," says Jeffrey R. Peterson, Ph.D, an assistant professor Fox Chase's Cancer Genetics and Signaling program and co-author of the article. "The structure of active site, however, is often shared among kinases, which makes it tough to target a particular kinase without accidentally inhibiting a related enzyme."

"By targeting PAK1's specific regulatory domain, IPA-3 is highly selective molecule that takes a more-or-less backdoor approach to shutting down a kinase, " Peterson says. "If we can create drugs that take advantage of this mechanism, we could create new combination therapies that will allow doctors to kill what might otherwise be drug-resistant cells."

Peterson and Julien Viaud, a postdoctoral researcher in the Peterson lab, published their findings in the journal Molecular Cancer Therapeutics, available online now. The researchers previously identified IPA-3 from a screen of 33,000 candidates, and the molecule has since gone on to become an important subject of study by cancer laboratories around the world. In the article, the researchers use a variety of techniques to define how IPA-3 interacts with PAK1.

"We found definitive proof that IPA-3 fit into and binds to PAK1's autoregulatory domain, the part of the enzyme where it can, essentially, shut itself off when necessary," Peterson says. "Our tests also demonstrate that IPA-3 is highly selective for PAK1, which means that it is less likely it will also turn off other kinases unintentionally."

The idea is not entirely without precedent, the cancer drug Gleevec, for example, is unusually selective for its target by binding to a region outside of the active site that is less common among kinases. By defining the regulatory domain as a useful target for inhibition, however, researchers now have a specific place to look when trying to develop new therapeutics for protein regulation, Peterson says.

According to Peterson, small molecule inhibitors such as IPA-3, are promising tools for drug discovery. While IPA-3 itself might not be a suitable as a drug for use in humans, the molecule could form the conceptual basis of a new targeted therapeutic.

The study was funded by grants from the National Institutes of Health, the Department of Defense Neurofibromatosis Research Program, an AACR-Fox Chase Cancer Center Career Development Award, the Fondation pour la Rescherche Mιdicale, the National Cancer Institute, and the Commonwealth of Pennsylvania Department of Health.

The initial screening that resulted in the identification of IPA-3 was made possible through a generous donation by the Gralla Family to Fox Chase Professor Jonathan Chernoff, M.D., Ph.D.


Story Source:

The above story is based on materials provided by Fox Chase Cancer Center. Note: Materials may be edited for content and length.


Cite This Page:

Fox Chase Cancer Center. "Enzyme Inhibitor Takes An Unexpected Approach Toward Blocking Cancer-promoting Protein." ScienceDaily. ScienceDaily, 9 September 2009. <www.sciencedaily.com/releases/2009/09/090908023654.htm>.
Fox Chase Cancer Center. (2009, September 9). Enzyme Inhibitor Takes An Unexpected Approach Toward Blocking Cancer-promoting Protein. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2009/09/090908023654.htm
Fox Chase Cancer Center. "Enzyme Inhibitor Takes An Unexpected Approach Toward Blocking Cancer-promoting Protein." ScienceDaily. www.sciencedaily.com/releases/2009/09/090908023654.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) — You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) — The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) — Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
Can You Train Your Brain To Eat Healthy?

Can You Train Your Brain To Eat Healthy?

Newsy (Sep. 1, 2014) — New research says if you condition yourself to eat healthy foods, eventually you'll crave them instead of junk food. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins